Animal study · mice

FOXO4-DRI eased age-related testosterone shortfall in aged mice

Checked against the paper Animal studyPublished by PepVault

The takeaway

This is early mouse and cell evidence that FOXO4-DRI can target aged testosterone-making cells. It does not show the same effect in people.

Kind
Animal study
Studied in
Mice
Published
2020
Journal
Aging (Albany NY)

What they tested

The team tested whether FOXO4-DRI could clear aged Leydig cells, the testis cells that make testosterone, and restore testosterone output in older male mice.

How the study was done

A lab study that looked at FOXO4 in human Leydig cells, then tested FOXO4-DRI on mouse TM3 Leydig cells pushed into senescence (an aged, non-dividing state) with hydrogen peroxide, and finally in naturally aged mice.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking FOXO4-DRI? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

In lab-grown mouse Leydig cells pushed into senescence, FOXO4 helped the aged cells survive and held back apoptosis (programmed cell death). FOXO4-DRI, a FOXO4 blocker that breaks its bond with a protein called p53, pushed p53 out of the nucleus and set off cell death specifically in the senescent cells. In old mice that had aged naturally, the treatment made conditions inside the testis better and reduced the age-linked drop in testosterone release. Separately, in human Leydig cells, FOXO4 shifting into the nucleus in older people went along with lower testosterone production.

What it doesn’t show

The treatment results come from a mouse cell line and aged mice, not from people. The study did not test FOXO4-DRI in men with late-onset hypogonadism (low testosterone that starts with age).

The paper

Zhang et al. FOXO4-DRI alleviates age-related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice. Aging (Albany NY). 2020.

The compound

More studies on FOXO4-DRI

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking FOXO4-DRI? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo